If you have been managing arthritis for years, you know that medication is often a balancing act. You are weighing the benefit of pain relief or inflammation control against the reality of potential long-term side effects. It is a common source of anxiety for patients I worked with during my 12 years in rheumatology clinics: "How long can I actually stay on these?"
If you are experiencing new symptoms, or simply feeling the wear and tear of long-term pharmaceutical use, it is time to have a structured, evidence-based conversation with your healthcare team. This guide will help you navigate your options within the NHS system.
Understanding Long-Term Arthritis Management
Arthritis is an umbrella term for a range of conditions, primarily Osteoarthritis (OA), Rheumatoid Arthritis (RA), and Psoriatic Arthritis (PsA). While the conditions differ, the management pathway usually follows a similar hierarchy:
- Lifestyle interventions: Weight management, low-impact exercise, and physiotherapy. Pain relief: Simple analgesics like paracetamol or topical NSAIDs. Anti-inflammatories: Oral NSAIDs (Non-Steroidal Anti-Inflammatory Drugs). Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Used to slow the progression of inflammatory arthritis. Biologics and targeted therapies: Advanced medications for those who do not respond to standard DMARDs.
Long-term use of these medications, particularly NSAIDs, can put a strain on your kidneys, heart, and stomach lining. If you feel like your medication is becoming the problem rather than the solution, you must bring this to your clinical team's attention.
Who Can Prescribe and Adjust Your Meds?
In the UK, it is vital to understand the chain of responsibility for your prescriptions:
- General Practitioners (GPs): Can manage basic pain relief and stable, long-term conditions. They are the frontline for monitoring side effects. Rheumatologists: Hospital consultants who manage complex inflammatory arthritis. If you are on "DMARDs" or "Biologics," these are typically initiated by a rheumatologist and sometimes shared-care with your GP. Pain Management Specialists: Often found in multidisciplinary pain clinics, they focus on complex pain scenarios that standard rheumatology may not fully address.
Never stop taking prescribed medication abruptly without consulting these professionals, as doing so can trigger a "flare" or cause withdrawal symptoms.
Common Medication Classes and Long-Term Concerns
The following table outlines common treatments and the potential areas of concern that patients often report to clinics.
Medication Class Primary Use Potential Long-Term Concern Oral NSAIDs (e.g., Ibuprofen, Naproxen) Pain/Inflammation Gastrointestinal bleeding, cardiovascular risk, kidney function. DMARDs (e.g., Methotrexate) RA/PsA control Liver toxicity, lung issues, frequent blood monitoring required. Corticosteroids (e.g., Prednisolone) Severe inflammation Bone density loss (osteoporosis), weight gain, skin thinning.
The "Talk to Specialist UK" Strategy
If you are worried about side effects, do not wait for your next annual review. You need to be proactive.
When you book an appointment, frame it clearly. Use this language: "I have been taking [medication name] for [duration]. I am concerned about [specific side effect]. I would like to discuss a medication review to see if there are alternative options or a way to reduce my dosage."
Your specialist may consider:
"Switching": Trying a different class of medication that works on a different pathway. "De-escalation": Slowly reducing the dose to the lowest effective amount. "Add-on therapies": Introducing non-drug treatments like physiotherapy or occupational therapy to reduce your reliance on pills.Always refer to the NHS England guidelines on medication safety, which emphasise that every patient has the right to a medication review at least once a year.
Medical Cannabis and Legislative Reality
Since 2018, medical cannabis has been legal in the UK when prescribed by a specialist doctor on the General Medical Council’s specialist register. However, there is a lot of misinformation online, often driven by US-centric advice that does not apply here.
In the UK, medical cannabis is not a "first-line" or even "second-line" treatment for arthritis. According to House of Commons Library research briefings, access remains extremely restricted and is usually only considered when all other conventional treatments (including high-strength painkillers and standard DMARDs) have failed to manage the condition.
If doctiplus.net you see advertisements for "CBD oil" or "medical cannabis" outside of an NHS/private consultant prescription, be extremely cautious. These products do not have the same rigorous evidence base or quality control as pharmaceutical-grade treatments approved by NICE (National Institute for Health and Care Excellence).
Consider Alternative Options
When medication reaches its limit, the answer is often "multimodal" care. This is a fancy way of saying you use several tools at once to lower your burden of meds:
- Physiotherapy: Strengthening the muscles around a joint can significantly reduce the load on the joint itself, decreasing pain levels. Occupational Therapy: Adapting your home or workstation can reduce the physical strain that leads to inflammation. Weight Management: For lower-limb arthritis, even a 5% reduction in body weight can have a dramatic impact on pain scores. Psychological support: Pain management programmes (PMPs) taught by the NHS can help you rewire how your brain processes chronic pain, potentially lowering the need for high-dose analgesics.
What Happens Next?
If you decide to raise these concerns, here is exactly how the process should unfold:
Remember: You are the expert in your own body. If a medication makes you feel unwell, you have the right to ask for a review. Never suffer in silence—there is always a professional who can help you adjust your path.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with your GP or rheumatologist before making changes to your prescribed treatment.